“…When clinical manifestations such as sudden lump enlargement or pelvic masses are present, the implementation with CT and MR becomes mandatory. Despite the very high specificity of MR for detecting origin and mass constitution (fat tissue), the diagnosis is made only after excluding other pelvic masses (benign cystic ovarian teratoma, malignant degeneration of cystic teratoma, lipomatous ovarian tumour, pelvic lipoma, liposarcoma and lipoblastic lymphadenopathy) [9,10,20,21]. CT and MR have allowed valid follow up of pelvic masses in one patient with severe medical contraindication to surgery [7] but pitfalls in imaging interpretation may always happen and one case with fatal consequences due to unnecessary surgery (lipoleiomyoma misdiagnosed as liposarcoma -patient died post hysterectomy) has been reported [22].…”